Rethinking multiple sclerosis treatment strategies

The landscape of multiple sclerosis treatment has substantially evolved over the past few years following the approval and commercialisation of several new drugs. Based on the mechanisms of action and efficacy and safety profiles of these drugs, for most patients one of two treatment approaches is normally used. The first approach, which focuses on safety, is escalation, and starts with lower risk disease-modifying therapies shifting to higher...